List of Excipients in API nelfinavir mesylate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing nelfinavir mesylate
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
HJ Harkins Company Inc | VIRACEPT | nelfinavir mesylate | 52959-289 | CALCIUM SILICATE | |
HJ Harkins Company Inc | VIRACEPT | nelfinavir mesylate | 52959-289 | CROSPOVIDONE | |
HJ Harkins Company Inc | VIRACEPT | nelfinavir mesylate | 52959-289 | FD&C BLUE NO. 2 | |
HJ Harkins Company Inc | VIRACEPT | nelfinavir mesylate | 52959-289 | HYPROMELLOSES | |
HJ Harkins Company Inc | VIRACEPT | nelfinavir mesylate | 52959-289 | MAGNESIUM STEARATE | |
HJ Harkins Company Inc | VIRACEPT | nelfinavir mesylate | 52959-289 | TRIACETIN | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for nelfinavir mesylate
Excipient focus: CALCIUM SILICATE
nelfinavir mesylate drug variants containing CALCIUM SILICATE
Company | Ingredient | NDC |
---|---|---|
HJ Harkins Company Inc | nelfinavir mesylate | 52959-289 |
State of Florida DOH Central Pharmacy | nelfinavir mesylate | 53808-0809 |
AGOURON | nelfinavir mesylate | 63010-010 |
>Company | >Ingredient | >NDC |
nelfinavir mesylate drug variants not containing CALCIUM SILICATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
nelfinavir mesylate drug variants containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
HJ Harkins Company Inc | nelfinavir mesylate | 52959-289 |
State of Florida DOH Central Pharmacy | nelfinavir mesylate | 53808-0809 |
AGOURON | nelfinavir mesylate | 63010-010 |
>Company | >Ingredient | >NDC |
nelfinavir mesylate drug variants not containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
nelfinavir mesylate drug variants containing FD&C BLUE NO. 2
Company | Ingredient | NDC |
---|---|---|
HJ Harkins Company Inc | nelfinavir mesylate | 52959-289 |
AGOURON | nelfinavir mesylate | 63010-010 |
>Company | >Ingredient | >NDC |
nelfinavir mesylate drug variants not containing FD&C BLUE NO. 2
Company | Ingredient | NDC |
---|---|---|
State of Florida DOH Central Pharmacy | nelfinavir mesylate | 53808-0809 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
nelfinavir mesylate drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
State of Florida DOH Central Pharmacy | nelfinavir mesylate | 53808-0809 |
AGOURON | nelfinavir mesylate | 63010-010 |
>Company | >Ingredient | >NDC |
nelfinavir mesylate drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
HJ Harkins Company Inc | nelfinavir mesylate | 52959-289 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
nelfinavir mesylate drug variants containing HYPROMELLOSES
Company | Ingredient | NDC |
---|---|---|
HJ Harkins Company Inc | nelfinavir mesylate | 52959-289 |
>Company | >Ingredient | >NDC |
nelfinavir mesylate drug variants not containing HYPROMELLOSES
Company | Ingredient | NDC |
---|---|---|
State of Florida DOH Central Pharmacy | nelfinavir mesylate | 53808-0809 |
AGOURON | nelfinavir mesylate | 63010-010 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
nelfinavir mesylate drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
HJ Harkins Company Inc | nelfinavir mesylate | 52959-289 |
State of Florida DOH Central Pharmacy | nelfinavir mesylate | 53808-0809 |
AGOURON | nelfinavir mesylate | 63010-010 |
>Company | >Ingredient | >NDC |
nelfinavir mesylate drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
nelfinavir mesylate drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
State of Florida DOH Central Pharmacy | nelfinavir mesylate | 53808-0809 |
>Company | >Ingredient | >NDC |
nelfinavir mesylate drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
HJ Harkins Company Inc | nelfinavir mesylate | 52959-289 |
AGOURON | nelfinavir mesylate | 63010-010 |
>Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
nelfinavir mesylate drug variants containing TRIACETIN
Company | Ingredient | NDC |
---|---|---|
HJ Harkins Company Inc | nelfinavir mesylate | 52959-289 |
State of Florida DOH Central Pharmacy | nelfinavir mesylate | 53808-0809 |
AGOURON | nelfinavir mesylate | 63010-010 |
>Company | >Ingredient | >NDC |
nelfinavir mesylate drug variants not containing TRIACETIN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.